Cargando…

A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer

BACKGROUND: Although many studies have determined that PD-L1 expression by immunohistochemistry can be somewhat predictive of a response to checkpoint inhibitor the impact of specific genomic changes and smoking history in the context of PD-L1 expression is limited. This single-center study examined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Michelle, Lipka, Mary Beth, Bhateja, Priyanka, Fu, Pingfu, Dowlati, Afshin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082292/ https://www.ncbi.nlm.nih.gov/pubmed/32206553 http://dx.doi.org/10.21037/tlcr.2020.01.03

Ejemplares similares

Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer
por: Bhateja, Priyanka, et al.
Publicado: (2019)

Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer
por: McColl, Karen, et al.
Publicado: (2017)

Comparing Survival in Patients With Lung Cancer With and Without a History of Common Autoimmune Disease
por: Dedousis, Demitrios, et al.
Publicado: (2022)

Mistletoe lectin inhibits growth of Myc‐amplified small‐cell lung cancer
por: Shatat, Mohammad A., et al.
Publicado: (2022)

RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR
por: Sakre, Nneha, et al.
Publicado: (2016)

A randomized controlled trial of structured palliative care versus standard supportive care for patients enrolled in phase 1 clinical trials
por: Treasure, Michelle, et al.
Publicado: (2021)

PIAS3 expression in squamous cell lung cancer is low and predicts overall survival
por: Abbas, Rime, et al.
Publicado: (2015)

MYC is downregulated by a mitochondrial checkpoint mechanism
por: Zhang, Xiaonan, et al.
Publicado: (2017)

Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status
por: Mirsky, Matthew M, et al.
Publicado: (2023)

Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer
por: Jain, Prantesh, et al.
Publicado: (2021)

Emerging Risk Factors and Prevention of Perioperative Pulmonary Complications
por: Bhateja, Priyanka, et al.
Publicado: (2014)

MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
por: Smith, Benjamin A. H., et al.
Publicado: (2023)

The Effects of smoking status and smoking history on patients with brain metastases from lung cancer
por: Shenker, Rachel F., et al.
Publicado: (2017)

MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer
por: Yi, Jingyan, et al.
Publicado: (2019)

Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer?
por: Pirker, Robert
Publicado: (2018)

Chloroquine induced utricaria—A detailed history helps
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Myc Is Required for Activation of the ATM-Dependent Checkpoints in Response to DNA Damage
por: Guerra, Lina, et al.
Publicado: (2010)

Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies
por: Caimi, Paolo F., et al.
Publicado: (2017)

Five checkpoints maintaining the fidelity of transcription by RNA polymerases in structural and energetic details
por: Wang, Beibei, et al.
Publicado: (2015)

Determinants of Resistance to Checkpoint Inhibitors
por: Tran, Linda, et al.
Publicado: (2020)

Muir-Torre Syndrome: The Importance of a Detailed Family History
por: Burris, Christopher K.H., et al.
Publicado: (2019)

Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed–Platinum–Radiation in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer: Results of a Phase I Trial
por: Biswas, Tithi, et al.
Publicado: (2022)

Smoking history and the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
por: Chen, Da-Li, et al.
Publicado: (2021)

Salzburg criteria for nonconvulsive status epilepticus: Details matter
por: Leitinger, Markus, et al.
Publicado: (2019)

The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
por: Bhateja, Priyanka, et al.
Publicado: (2019)

Novel Delivery Systems for Checkpoint Inhibitors
por: Lamichhane, Purushottam, et al.
Publicado: (2019)

Poker-DVS and MNIST-DVS. Their History, How They Were Made, and Other Details
por: Serrano-Gotarredona, Teresa, et al.
Publicado: (2015)

Adrenal insufficiency from steroid-containing complementary therapy: importance of detailed history
por: Kempegowda, Punith, et al.
Publicado: (2019)

Beta-PSMC: uncovering more detailed population history using beta distribution
por: Liu, Junfeng, et al.
Publicado: (2022)

A case of humidifier lung; the key diagnosis is detailed medical history taking
por: Hara, Munechika, et al.
Publicado: (2023)

Medicare Calibration of the Clinically Detailed Risk Information System for Cost
por: Kapur, Kanika, et al.
Publicado: (2003)

Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma
por: Prince, Eric W., et al.
Publicado: (2016)

Book Review: Smoke: a global history of smoking
por: Berridge, Virginia
Publicado: (2006)

Details = Detalles = Details /
por: Haro Lebrija, Fernando de
Publicado: (2011)

Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017)

OTHR-15. PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER THAT RECUR WITH ISOLATED BRAIN METASTASES HAVE PROLONGED SURVIVAL
por: Bonder, Bryan, et al.
Publicado: (2019)

Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail
por: Tritz, Zachariah P, et al.
Publicado: (2021)

Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events: A Systematic Review and Meta-analysis
por: Farooq, Muhammad Zain, et al.
Publicado: (2022)

Framingham risk prediction equations for incidence of cardiovascular disease using detailed measures for smoking
por: Mannan, Haider, et al.
Publicado: (2010)

Developmental Context Determines Latency of MYC-Induced Tumorigenesis
por: Beer, Shelly, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_rf7d6gu5ulr01v4s9l8gqtudi8